Jul. 31 at 2:05 PM
$VNDA low volume shows no desperation. Seems quite many investors are indifferent of those miserable numbers and have been awaiting fro the only outcome - a new buy out offer. Company spends a lot in new sales team, however, it still has to prove sales numbers (most likely - its harder than thought), thus either a big pharma with an existing networks already or PE firm my step into to boost sales, profitability and shareholders value. Its a pity it takes so long, but patience is a friend.
